Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastoma

Show other versions (1)

https://doi.org/10.18632/oncotarget.10692 Eric W. Prince, Ilango Balakrishnan, Monil Shah, Jean M. Mulcahy Levy, Andrea M. Griesinger, Irina Alimova, Peter S. Harris, Diane K. Birks, Andrew M....

Saved in:

Bibliographic Details
Main Authors:	Prince, Eric W. (Author) , Remke, Marc (Author)
Format:	Article (Journal)
Language:	English
Published:	July 19, 2016
In:	OncoTarget Year: 2016, Volume: 7, Issue: 33, Pages: 53881-53894
ISSN:	1949-2553
DOI:	10.18632/oncotarget.10692
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.18632/oncotarget.10692 Verlag, lizenzpflichtig, Volltext: https://www.oncotarget.com/article/10692/text/
Author Notes:	Eric W. Prince, Ilango Balakrishnan, Monil Shah, Jean M. Mulcahy Levy, Andrea M. Griesinger, Irina Alimova, Peter S. Harris, Diane K. Birks, Andrew M. Donson, Nathan Davidson, Marc Remke, Michael D. Taylor, Michael H. Handler, Nicholas K. Foreman, Sujatha Venkataraman, Rajeev Vibhakar

Description
Summary:	https://doi.org/10.18632/oncotarget.10692 Eric W. Prince, Ilango Balakrishnan, Monil Shah, Jean M. Mulcahy Levy, Andrea M. Griesinger, Irina Alimova, Peter S. Harris, Diane K. Birks, Andrew M....
Item Description:	Gesehen am 29.01.2021
Physical Description:	Online Resource
ISSN:	1949-2553
DOI:	10.18632/oncotarget.10692